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Neonatal diabetes, which can be transient or permanent, is defined as hyperglycemia that presents within the first
month of life and requires insulin therapy. Transient neonatal diabetes mellitus has been associated with abnor-
malities of the paternally inherited copy of chromosome 6, including duplications of a portion of the long arm of
chromosome 6 and uniparental disomy, implicating overexpression of an imprinted gene in this disorder. To date,
all patients with transient neonatal diabetes mellitus and uniparental disomy have had complete paternal isodisomy.
We describe a patient with neonatal diabetes, macroglossia, and craniofacial abnormalities, with partial paternal
uniparental disomy of chromosome 6 involving the distal portion of 6q, from 6q24-qter. This observation dem-
onstrates that mitotic recombination of chromosome 6 can also give rise to uniparental disomy and neonatal
diabetes, a situation similar to that observed in Beckwith-Wiedemann syndrome, another imprinted disorder. This
finding has clinical implications, since somatic mosaicism for uniparental disomy of chromosome 6 should also be
considered in patients with transient neonatal diabetes mellitus.
Neonatal diabetes mellitus is a rare disorder, having an
estimated incidence of ∼1 in 400,000 live births (von
Muhlendahl and Herkenhoff 1995). Infants with this
disorder present within the first month of life with hy-
perglycemia that lasts for 2 wk and that requires in-
sulin therapy (Fosel 1995; von Muhlendahl and Her-
kenhoff 1995; Shield et al. 1997). Other features include
intrauterine growth retardation and, in rarer instances,
macroglossia and umbilical and inguinal hernias (Ger-
rard and Chin 1962; Salerno et al. 1994; Battin et al.
1996; Shield et al. 1997). Neonatal diabetes can be tran-
sient or permanent. Transient neonatal diabetes mellitus
(TNDM [MIM 601410]) accounts for more than half
the patients with neonatal diabetes mellitus and requires
exogenous insulin therapy to maintain euglycemia.
TNDM usually resolves at a median age of 4 mo (Fosel
1995; von Muhlendahl and Herkenhoff 1995). An in-
creased risk of developing diabetes, particularly type 2
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diabetes, later in life has been observed in some patients
with TNDM (Shield and Baum 1995; von Muhlendahl
and Herkenhoff 1995). Macroglossia appears to be a
feature more commonly associated with TNDM than
with the permanent form of neonatal diabetes (Christian
et al. 1999).
TNDM has been associated with abnormalities in-
volving chromosome 6. To date, the genetic abnormal-
ities identified in patients with TNDM include paternal
uniparental disomy of chromosome 6 (UPD6pat) (Abra-
mowicz et al. 1994; Temple et al. 1995; Whiteford et
al. 1997; Gardner et al. 1998; Christian et al. 1999; Cave
et al. 2000; Hermann et al. 2000; Marquis et al. 2000)
and duplications involving the 6q22-q24 region of the
paternally derived chromosome 6 (Temple et al. 1996;
Arthur et al. 1997; Gardner et al. 1999; Cave et al.
2000). These findings have suggested the involvement of
an imprinted gene(s) in this disorder expressed only from
the paternal chromosome and that increased expression,
either by paternal UPD or duplication, results in the
diabetes phenotype. This hypothesis is supported by the
absence of the diabetic phenotype in instances of ma-
ternal UPD of chromosome 6 (van den Berg-Loonen et
al. 1996; Spiro et al. 1999). UPD is generally associated
with meiotic nondisjunction events followed by trisomy
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or monosomy “rescue” (Spence et al. 1988; Nicholls
1991). Most instances of UPD are thought to occur be-
cause of maternal meiosis I nondisjunction, associated
with advanced maternal age; paternal UPD is thought
to arise from a postzygotic duplication of a monosomic
conception (Ledbetter and Engel 1995). To date, all in-
stances of UPD6pat in patients with TNDM have been
isodisomic (i.e., two copies of chromosome 6 are iden-
tical) and complete (i.e., involving the entire chromo-
some 6), which is consistent with a postzygotic dupli-
cation of the paternally derived chromosome 6. More
recently, methylation changes of an imprinted locus in
6q24 have also been implicated in TNDM (Gardner et
al. 2000).
We have identified a patient with neonatal diabetes
and macroglossia, who has only partial UPD6pat in-
volving the distal portion of 6q. This finding is, to our
knowledge, the first reported instance of a patient with
neonatal diabetes mellitus and partial UPD6pat. As par-
tial UPD can arise only because of a somatic crossover
event, this finding indicates that UPD6 in neonatal di-
abetes can also arise by mitotic recombination. The lim-
itation of UPD to the distal portion of 6q is consistent
with the finding of 6q22-q24 duplications in patients
with TNDM and further supports the localization of an
imprinted gene(s) to this region of chromosome 6.
The patient, a Hispanic male infant whose parents are
nonconsanguineous, was born at 32 wk gestation. He
had a brother with myoclonic seizures and severe mental
retardation, for whom an extensivemetabolic evaluation
revealed nothing. No one in the family was reported to
have had diabetes mellitus. The patient’s length was 43
cm, his weight 1.79 kg (both 75th percentile), and his
head circumference 30 cm (50th percentile). He had ex-
treme macroglossia, a prominent occiput, lambdoidal
ridging, small fontanel, shallow orbits, prominent nose,
dysmorphic ears, gingival and labial hypertrophy, high
palate, micrognathia, and a patent ductus arteriosus.
Overall, subcutaneous tissue was decreased. Serum glu-
cose was 452 mg/dl on day 2 of life and remained mark-
edly elevated, despite treatment with a continuous in-
sulin infusion. His respiratory status required very
aggressive support. He also had intermittent hypoten-
sion, requiring treatment with pressor agents. On day
10, a bronze tinge to the skin was noted. Serum iron
was low, at 27 mg/dl (normal 42–135), the ferritin level
was 834 ng/ml (normal 15–400), and transferrin was
!100 mg/dl (normal 200–400). On day 12, he was pale
and cyanotic, with complete opacification of his lungs.
Despite aggressive therapy, he died on day 14 from Pseu-
domonas aeruginosa sepsis. He had a normal cortisol
level of 12.9 mg/dl and an insulin level of 9 mU/ml (nor-
mal 5–25), obtained immediately prior to death, while
he was still receiving the insulin infusion. On postmor-
tem examination, gastric ulcers, laryngeal erosions, mul-
tiple necrotizing lung abscesses, and vasculitis were de-
tected. Hyaline membrane disease and the patent ductus
arteriosis were also confirmed. No histologic abnor-
malities of either the exocrine or endocrine pancreas
were detected. Despite the suspected hemochromatosis,
there was no evidence of excess iron storage. However,
there was hemosiderosis of the liver, assumed to be sec-
ondary to repeated blood transfusions.
Because of the marked hyperglycemia and macro-
glossia observed in this patient, microsatellite analysis
for UPD6 was performed. DNA was extracted from the
peripheral blood samples of the patient and both par-
ents, by means of the Puregene kit from Gentra systems,
according to the manufacturer’s recommendations. For
the initial analysis, sevenmicrosatellitemarkers thatmap
to chromosome 6 were used. Five of the seven markers
(D6S1713, D6S389, D6S1613, D6S1639, and D6S435)
showed normal biparental inheritance; however, the two
most distal 6q markers used (D6S311 and D6S305),
which map to 6q25.1 and 6q26, respectively, showed
absence of a maternal allele and presence of a single
paternal allele, in the patient’s blood sample (data not
shown). These results are consistent with a partial iso-
disomy of the paternally derived chromosome 6, re-
stricted to the distal 6q region. Chromosome analysis
showed a normal male karyotype, 46,XY. In order to
rule out a submicroscopic deletion of the distal 6q region
of the maternally derived chromosome 6, FISH analysis
was performed using a probe, PAC 196I5, which maps
within 300 bp of the telomere of chromosome 6q
(Knight et al. 2000). The probe was directly labeled with
SpectrumGreen-dUTP (Vysis), using a standard nick-
translation reaction. Slide preparation, probe prepara-
tion, and hybridization were completed using methods
described elsewhere (Chong et al. 1997). Two hybridi-
zation signals were observed, indicating that there was
no deletion of the 6q telomeric region (data not shown).
An additional five microsatellite markers (D6S980,
D6S1599, D6S1719, D6S264, and D6S281), which map
distal to 6q26 and extend to the 6q telomeric region,
were analyzed. For all five markers tested, the patient
was found to have inherited only a single paternal allele.
These results, together with the normal cytogenetic and
FISH analysis in this patient, confirmed the presence of
partial UPD6pat and indicated that the UPD extended
to the end of the long arm of chromosome 6. To more
precisely localize the position of the somatic crossover
event that defines the boundary of the partial UPD in
this patient, five additional microsatellitemarkers,which
map between D6S435 and D6S311 (the markers found
to flank the somatic recombination event in the initial
screen), were used to study the patient. These mark-
ers were D6S262, D6S292, D6S1009, D6S314, and
D6S1003. The somatic recombination event was local-
ized between markers D6S292 and D6S1009, which
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Table 1
Analysis of Results of Microsatellite Markers
Locusa
(pterrqter) Father Patient Mother Result
D6S1713 1,3 1,4 2,4 Biparental
D6S389 1,3 1,4 2,4 Biparental
D6S1613 3,4 1,4 1,2 Biparental
D6S1639 2,3 1,3 1,1 Biparental
D6S435 2,3 1,3 1,1 Biparental
D6S262 1,2 1,1 1,1 Uninformative
D6S292 1,3 2,3 2,2 Biparental
D6S1009 2,2 2,2 1,1 Paternal UPD
D6S314 2,3 2,2 1,1 Paternal UPD
D6S1003 1,3 3,3 2,2 Paternal UPD
D6S311 1,2 2,2 3,3 Paternal UPD
D6S305 2,3 2,2 1,4 Paternal UPD
D6S980 1,1 1,1 2,3 Paternal UPD
D6S1599 1,4 4,4 2,3 Paternal UPD
D6S1719 3,4 3,3 1,2 Paternal UPD
D6S264 3,3 3,3 1,2 Paternal UPD
D6S281 1,4 1,1 2,3 Paternal UPD
a The markers are arranged in order from the distal end
of the short arm to the distal end of the long arm of chro-
mosome 6.
Figure 1 Somatic recombination resulting in paternal isodisomy
for the distal portion of 6q. Mitotic recombination and random seg-
regation of sister chromatids can result in other cell populations with
maternal isodisomy and biparental inheritance of chromosome 6. The
extent of mosaicism will depend on the stage at which the recombi-
national event occurs.
map to chromosome band 6q23.2 and 6q24.1, respec-
tively, according to the Genome Database. The genetic
map positions of the markers used are based on the
genetic maps of the Center for Medical Genetics and of
Ge´ne´thon (Dib et al. 1996), as well as the chromosome
6 radiation-hybrid map of The Sanger Centre. The re-
sults of the microsatellite analysis are presented in table
1. All the markers that showed UPD showed a single
paternal allele, indicative of paternal isodisomy for
6q24-qter. UPD analysis of the patient’s brother with
developmental delay, seizures, and severe neurologic dis-
ease of unknown etiology showed normal biparental in-
heritance of chromosome 6.
Our results demonstrate the presence of partial
UPD6pat, involving only the distal portion of 6q, in a
patient with neonatal diabetes and macroglossia. This
patient is, to our knowledge, the first such identified case.
Since our patient died on day 14 of sepsis, we do not
know whether the diabetes in this patient would have
been transient or permanent. However, we speculate that
it would have been transient, since chromosome 6 ab-
normalities have been associated with TNDM rather
than with the permanent form of neonatal diabetes
(Christian et al. 1999; Hermann et al. 2000). Chro-
mosome 6 duplications and UPD6pat appear to be re-
sponsible for approximately two-thirds of TNDM pa-
tients (Gardner et al. 1999; Temple et al. 1999). More
recently, submicroscopic duplications and methylation
mutations of the 6q24 region have been found in patients
with TNDM, implying that perhaps more subtle changes
of chromosome 6 may be involved in the remaining cases
(Gardner et al. 2000). Our findings imply that mitotic
recombination and partial UPD, possibly associatedwith
mosaicism, also account for a proportion of patients
with neonatal diabetes mellitus.
Only a postzygotic mitotic recombination event can
account for a partial UPD finding. Somatic crossover
between the two copies of chromosome 6 at mitosis,
followed by random segregation of sister chromatids in
the zygote, is likely to have given rise to the partial UPD6
observed in this patient. Somatic recombination and ran-
dom segregation can produce different cell types, as il-
lustrated in figure 1. This mechanism can result in so-
matic mosaicism, the extent of which will depend on
which stage the postzygotic recombinational event oc-
curred. Somatic recombination at a very early stage, fol-
lowed by preferential death of a particular cell type, may
be the cause of the lack of mosaicism observed in this
patient. It is also possible that a low level of mosaicism
in this patient may have been undetected. Additionally,
the study of other tissues in this patient may have re-
vealed somemosaicism; however, only lymphocyteswere
available for study.
The observation of partial UPD6 in neonatal diabetes
is similar to the situation of Beckwith-Wiedemann syn-
drome (BWS), another imprinting disorder associated
with overgrowth, umbilical anomalies, macroglossia,
and, conversely to UPD6, transient neonatal hypogly-
cemia. In BWS, partial paternal UPD of chromosome
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11, paternal duplications of 11p, and gene mutations
that affect imprinting have been observed (reviewed by
Li et al. 1998). Somatic mosaicism has been observed
in a number of patients with BWS who have either par-
tial or total UPD11pat (Henry et al. 1993; Bischoff et
al. 1995; Catchpoole et al. 1997). The presence of so-
matic mosaicism, as well as the different genetic mech-
anisms that give rise to BWS, are thought to be the cause
of the highly variable phenotype seen in this disorder
(Henry et al. 1993; Catchpoole et al. 1997). The ob-
servation of partial UPD6pat in a child with neonatal
diabetes suggests that somatic mosaicism may be present
in some cases of TNDM as well. The presence of com-
plete UPD6, duplications of chromosome 6, 6q24 meth-
ylation mutations, and now partial UPD6 may contrib-
ute to the variability in phenotype that is seen in patients
with TNDM, as is the case with BWS.
One other patient with partial UPD6pat has been re-
ported (Lopez-Gutierrez et al. 1998), but the UPD in-
volved only the short arm of chromosome 6. The phe-
notype of the patient was notable for congenital adrenal
hypoplasia caused by homozygosity for a paternally
transmitted point mutation in the steroid 21-hydroxy-
lase gene at 6p21.3. However, this patient did not have
neonatal diabetes, consistent with the UPD not extend-
ing to the long arm of chromosome 6. In contrast, the
extent of the paternal UPD in our patient is consistent
with and overlaps the area of paternal duplications ob-
served in patients with TNDM (Gardner et al. 1999;
Cave et al. 2000). The inclusion of the 6q24 region in
the UPD observed in this patient supports the localiza-
tion of an imprinted gene(s) involved in neonatal dia-
betes to this region of chromosome 6 (Gardner et al.
1999, 2000; Cave et al. 2000). A candidate gene for
TNDM, ZAC/PLAGL1, which maps to 6q24 and ap-
pears to be imprinted, has recently been described (Ka-
miya et al. 2000). Other loci implicated in insulin-de-
pendent diabetes mellitus (IDDM) have been localized
to the long arm of chromosome 6 by linkage analysis
(Luo et al. 1995, 1996; Davies et al. 1996; Delepine et
al. 1997), and it may be speculated that the genes at one
or more of these loci may also play a role in TNDM.
To date, all patients with TNDM and UPD6pat have
had intrauterine growth retardation (Abramowicz et al.
1994; Temple et al. 1995; Whiteford et al. 1997; Gard-
ner et al. 1998; Christian et al. 1999; Cave et al. 2000;
Hermann et al. 2000; Marquis et al. 2000). Even though
our patient’s growth parameters, including his weight,
were in the normal range, he did have an apparent
marked decrease in subcutaneous tissue. From the extent
of UPD present in our patient, however, we might spec-
ulate that at least some gene(s) responsible for growth
retardation maps proximal to 6q24. Macroglossia has
been specifically mentioned in a proportion of TNDM
patients with UPD6pat (Christian et al. 1999; Cave et
al. 2000; Hermann et al. 2000). From the extent of UPD
in our patient, we can speculate that the locus respon-
sible for macroglossia maps distal to 6q24. The mech-
anism is more likely to be related to imprinting than to
rare recessive genes unmasked by UPD, since macro-
glossia and intrauterine growth retardation are specific
findings in more than one of these patients. It should be
noted that, analogously, macroglossia is quite variably
associated with BWS. Thus, it is likely that macroglossia
associated with UPD6 is also influenced by other genetic
and environmental factors.
Our patient also had several dysmorphic features that
have not been associated with TNDM. Two other pa-
tients with neonatal diabetes and abnormalities of chro-
mosome 6, with death in infancy, have been described
in the literature (Pivnick et al. 1990; Abramowicz et al.
1994). For both these patients, the genetic basis for the
severity in phenotype was determined and included a
reduction to homozygosity for a MUT gene mutation
(Abramowicz et al. 1994) and the presence of an un-
balanced chromosome translocation involving chro-
mosome 6 (Pivnick et al. 1990). Another example of a
patient with an unbalanced chromosome translocation
involving chromosome 6 and death in infancy has been
reported; however, neonatal diabetes was not mentioned
with regard to this patient (Franchino et al. 1987). No
karyotypic abnormalities were observed in our patient
that would account for the severity of the phenotype.
Although it is possible that the patient inherited a re-
cessive mutation, which became reduced to homozy-
gosity, from the father, no other specific syndrome could
be assigned to the patient.
Intriguing observations in the patient were the iron,
ferritin, and transferrin indices, which were suggestive
of hereditary hemochromatosis. As the HFE gene for
hereditary hemochromatosis maps to chromosome 6 at
6p21.3, we had initially speculated a total UPD6pat in
this patient resulting in a reduction to homozygosity of
a mutation in the HFE gene inherited from the father.
However, the UPD was found not to extend to the short
arm of chromosome 6, and analysis of the HFE gene
for the common C282Ymutation and theH63D variant,
performed as described elsewhere (Feder et al. 1996),
showed that the patient had inherited only one allele of
the H63D variant, which is not sufficient for the man-
ifestation of hereditary hemochromatosis. Both parents
were found to be carriers of the H63D allele, and the
parental origin of the H63D allele in the patient could
not easily be determined. Thus, the elevated ferritin level
may have been a nonspecific acute-phase reactant, rather
than a primary abnormality. It is also interesting to note
that the pancreas in our subject appeared to be normal
on postmortem examination. Unfortunately, stains spe-
cific for pancreatic beta cells were not performed in our
patient, so we cannot be certain if there was selective
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agenesis of these cells, as was observed in the subject
reported by Abramowicz et al. (1994).
In summary, we describe a patient with neonatal di-
abetes, macroglossia, and other complications, including
neonatal death due to sepsis, who had a partial UPD6pat
involving distal 6q from 6q24-qter. This is the first de-
scription of a patient with neonatal diabetes, macro-
glossia, and partial UPD6pat. This observation further
reinforces the complexity of the genetic basis of neonatal
diabetes and emphasizes the importance of using poly-
morphic markers that map distal to the 6q24 region for
molecular diagnosis of UPD6 in neonatal diabetes.
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